These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Syndromes of Thrombotic Microangiopathy. Shatzel JJ; Taylor JA Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178 [TBL] [Abstract][Full Text] [Related]
6. VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience. Ozawa M; Ohtani H; Komatsuda A; Wakui H; Takahashi N Clin Exp Nephrol; 2021 Nov; 25(11):1193-1202. PubMed ID: 34115234 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of thrombotic microangiopathy: insights from animal models. Richards A; Kavanagh D Nephron Exp Nephrol; 2009; 113(4):e97-103. PubMed ID: 19684414 [TBL] [Abstract][Full Text] [Related]
8. Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy. Pfister F; Amann K; Daniel C; Klewer M; Büttner A; Büttner-Herold M Histopathology; 2018 Dec; 73(6):990-1001. PubMed ID: 30014486 [TBL] [Abstract][Full Text] [Related]
9. Thrombotic microangiopathy and purtscher-like retinopathy associated with adult-onset Still's disease: a role for glomerular vascular endothelial growth factor? El Karoui K; Karras A; Lebrun G; Charles P; Arlet JB; Jacquot C; Orssaud C; Nochy D; Pouchot J Arthritis Rheum; 2009 Nov; 61(11):1609-13. PubMed ID: 19877102 [No Abstract] [Full Text] [Related]
12. The role of von Willebrand factor in thrombotic microangiopathy. Noone DG; Riedl M; Licht C Pediatr Nephrol; 2018 Aug; 33(8):1297-1307. PubMed ID: 28748411 [TBL] [Abstract][Full Text] [Related]
16. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Furlan M; Lämmle B Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108 [TBL] [Abstract][Full Text] [Related]
17. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies. Moake J Best Pract Res Clin Haematol; 2009 Dec; 22(4):567-76. PubMed ID: 19959109 [TBL] [Abstract][Full Text] [Related]
18. Update on the role of the complement system in the pathogenesis of thrombotic microangiopathies. Sinkovits G; Prohászka Z Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2014; 35(1):115-22. PubMed ID: 24802312 [TBL] [Abstract][Full Text] [Related]
19. The endothelium as the common denominator in malignant hypertension and thrombotic microangiopathy. Mathew RO; Nayer A; Asif A J Am Soc Hypertens; 2016 Apr; 10(4):352-9. PubMed ID: 26778772 [TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathy with renal injury: an approach for the general physician. Htet Z; Karim M J R Coll Physicians Edinb; 2020 Mar; 50(1):25-31. PubMed ID: 32539032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]